TD Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $102M | Buy |
228,195
+45,582
| +25% | +$21.3M | 0.08% | 188 |
|
|
2025
Q4 | $82.8M | Sell |
182,613
-34,926
| -16% | -$15.1M | 0.07% | 220 |
|
|
2025
Q3 | $85.2M | Sell |
217,539
-247,634
| -53% | -$103M | 0.07% | 223 |
|
|
2025
Q2 | $207M | Sell |
465,173
-20,683
| -4% | -$9.53M | 0.18% | 121 |
|
|
2025
Q1 | $236M | Buy |
485,856
+16,788
| +4% | +$7.82M | 0.22% | 93 |
|
|
2024
Q4 | $189M | Sell |
469,068
-53,137
| -10% | -$24.6M | 0.17% | 128 |
|
|
2024
Q3 | $242M | Buy |
522,205
+18,151
| +4% | +$8.72M | 0.21% | 104 |
|
|
2024
Q2 | $236M | Sell |
504,054
-11,346
| -2% | -$4.92M | 0.22% | 102 |
|
|
2024
Q1 | $215M | Sell |
515,400
-18,513
| -3% | -$7.83M | 0.2% | 113 |
|
|
2023
Q4 | $217M | Buy |
533,913
+53,850
| +11% | +$19.9M | 0.21% | 91 |
|
|
2023
Q3 | $167M | Buy |
480,063
+103,097
| +27% | +$36.1M | 0.2% | 90 |
|
|
2023
Q2 | $133M | Sell |
376,966
-9,620
| -2% | -$3.24M | 0.15% | 120 |
|
|
2023
Q1 | $122M | Buy |
386,586
+6,572
| +2% | +$1.97M | 0.15% | 128 |
|
|
2022
Q4 | $110M | Sell |
380,014
-59,581
| -14% | -$18.2M | 0.14% | 133 |
|
|
2022
Q3 | $129M | Sell |
439,595
-1,946
| -0.4% | -$560K | 0.16% | 112 |
|
|
2022
Q2 | $124M | Buy |
441,541
+4,975
| +1% | +$1.33M | 0.14% | 126 |
|
|
2022
Q1 | $114M | Buy |
436,566
+106,787
| +32% | +$25.3M | 0.1% | 155 |
|
|
2021
Q4 | $72.4M | Buy |
329,779
+9,855
| +3% | +$1.92M | 0.06% | 244 |
|
|
2021
Q3 | $58M | Sell |
319,924
-25,689
| -7% | -$5.02M | 0.06% | 247 |
|
|
2021
Q2 | $69.7M | Sell |
345,613
-134,074
| -28% | -$28M | 0.07% | 226 |
|
|
2021
Q1 | $103M | Sell |
479,687
-122,706
| -20% | -$27M | 0.12% | 141 |
|
|
2020
Q4 | $142M | Sell |
602,393
-18,348
| -3% | -$4.21M | 0.17% | 110 |
|
|
2020
Q3 | $169M | Buy |
620,741
+28,773
| +5% | +$7.94M | 0.23% | 90 |
|
|
2020
Q2 | $172M | Buy |
591,968
+11,139
| +2% | +$3.02M | 0.24% | 86 |
|
|
2020
Q1 | $138M | Buy |
580,829
+22,345
| +4% | +$5.13M | 0.23% | 88 |
|
|
2019
Q4 | $122M | Sell |
558,484
-10,495
| -2% | -$2.12M | 0.18% | 114 |
|
|
2019
Q3 | $96.4M | Buy |
568,979
+31,902
| +6% | +$5.64M | 0.15% | 134 |
|
|
2019
Q2 | $98.5M | Buy |
537,077
+17,903
| +3% | +$3.13M | 0.15% | 124 |
|
|
2019
Q1 | $95.5M | Buy |
519,174
+16,768
| +3% | +$3.1M | 0.15% | 122 |
|
|
2018
Q4 | $83.3M | Buy |
502,406
+10,202
| +2% | +$1.77M | 0.14% | 127 |
|
|
2018
Q3 | $94.9M | Buy |
492,204
+34,971
| +8% | +$6.23M | 0.14% | 134 |
|
|
2018
Q2 | $77.7M | Sell |
457,233
-44,008
| -9% | -$6.82M | 0.12% | 152 |
|
|
2018
Q1 | $81.7M | Buy |
501,241
+12,868
| +3% | +$2.1M | 0.13% | 150 |
|
|
2017
Q4 | $73.2M | Buy |
488,373
+36,133
| +8% | +$5.35M | 0.11% | 160 |
|
|
2017
Q3 | $68.8M | Buy |
452,240
+18,513
| +4% | +$2.79M | 0.1% | 158 |
|
|
2017
Q2 | $55.9M | Buy |
433,727
+22,057
| +5% | +$2.66M | 0.09% | 181 |
|
|
2017
Q1 | $45M | Buy |
411,670
+18,884
| +5% | +$1.66M | 0.07% | 215 |
|
|
2016
Q4 | $28.9M | Sell |
392,786
-52,358
| -12% | -$4.26M | 0.05% | 287 |
|
|
2016
Q3 | $38.8M | Sell |
445,144
-247
| -0.1% | -$23.3K | 0.07% | 232 |
|
|
2016
Q2 | $38.3M | Sell |
445,391
-19,698
| -4% | -$1.7M | 0.07% | 225 |
|
|
2016
Q1 | $37M | Buy |
465,089
+39,905
| +9% | +$3.61M | 0.07% | 223 |
|
|
2015
Q4 | $53.5M | Buy |
425,184
+47,550
| +13% | +$5.74M | 0.11% | 167 |
|
|
2015
Q3 | $39.3M | Buy |
377,634
+58,300
| +18% | +$7.49M | 0.08% | 206 |
|
|
2015
Q2 | $39.4M | Buy |
319,334
+724
| +0.2% | +$91.2K | 0.07% | 208 |
|
|
2015
Q1 | $37.6M | Buy |
318,610
+16,282
| +5% | +$1.95M | 0.07% | 223 |
|
|
2014
Q4 | $35.9M | Buy |
302,328
+7,475
| +3% | +$842K | 0.06% | 225 |
|
|
2014
Q3 | $33.1M | Buy |
294,853
+6,227
| +2% | +$593K | 0.06% | 240 |
|
|
2014
Q2 | $27.3M | Buy |
288,626
+31,200
| +12% | +$2.19M | 0.05% | 268 |
|
|
2014
Q1 | $18.2M | Buy |
257,426
+11,800
| +5% | +$935K | 0.03% | 341 |
|
|
2013
Q4 | $18.3M | Buy |
245,626
+36,100
| +17% | +$2.51M | 0.03% | 324 |
|
|
2013
Q3 | $15.9M | Buy |
209,526
+112,800
| +117% | +$8.98M | 0.03% | 336 |
|
|
2013
Q2 | $7.73M | Buy |
+96,726
| New | +$7.12M | 0.02% | 476 |
|
Other funds holding VRTX
VCM
VPM
TD Asset Management's VRTX Position: Q1 2026 in Review
TD Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 25% in Q1 2026, buying an estimated $21.3M and bringing the position to 228,195 shares worth $102M. The position accounts for 0.08% of the portfolio, ranked #188.
TD Asset Management first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $242M in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- TD Asset Management held 228,195 shares of Vertex Pharmaceuticals worth $102M as of Q1 2026.
- TD Asset Management bought 45,582 Vertex Pharmaceuticals shares in Q1 2026, an estimated $21.3M.
- Vertex Pharmaceuticals made up 0.08% of TD Asset Management's portfolio in Q1 2026, its #188 holding.
- TD Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- TD Asset Management's Vertex Pharmaceuticals position peaked at $242M in Q3 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.